Source: Annual Congress 2005 - COPD, asthma and lung cancer in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Roche, P. Serrier, T. Perez, Y. Martinat, D. Huas, I. Chanal, C. Pribil, G. Huchon (Paris, Lille, Lyon, Marly Le Roi, France). Gap between spontaneously reported and measured dyspnoea in patients with or at risk of COPD. Eur Respir J 2005; 26: Suppl. 49, 4258

Member's Comments

No comment yet.

Related content which might interest you: Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Determinants of dyspnea in stable COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Co-morbidities are not associated with severity of airflow obstruction as measured by ATS/ERS/GOLD in patients with COPD Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Treating exacerbations of asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders? Year: 2010 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation versus stable COPD outpatients Source: International Congress 2014 – Comorbidities Year: 2014 Lung function and reported dyspnea in Greek COPD patients under treatment with fluticasone/salmeterol FDC via Elpenhaler device with or without cardiovascular comorbidity - AEOLOS study. Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Respiratory factors associated with dyspnea in women with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 806s Year: 2006 Are the predictors of dyspnea perception the same during the follow-up in COPD patients? Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Factors associated with improvement in breathing capacity during exercise in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 High prevalence of altered cardiac repolarization in patients with COPD Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015